Join Dr. Bruno Douradinha for a webinar on K. pneumoniae vaccine development, covering glycoconjugates, carbohydrate antigens, and formulation technologies.
Klebsiella pneumoniae poses a growing global threat due to rising multidrug resistance and hypervirulence. This talk reviews current vaccine approaches—including glycoconjugates, protein antigens, and OMVs—alongside key translation challenges like antigenic diversity and preclinical models.